1.A Scientometric Analysis of 20 Years of Research on Breast Reconstruction Surgery: A Guide for Research Design and Journal Selection.
Mehrdad MOGHIMI ; Mehdi FATHI ; Ali MARASHI ; Freshteh KAMANI ; Gholamreza HABIBI ; Armin HIRBOD-MOBARAKEH ; Marjan GHAEMI ; Mahdi HOSSEINIAN-SARAJEHLOU
Archives of Plastic Surgery 2013;40(2):109-115
BACKGROUND: Breast reconstruction refers to the rebuilding of a woman's breast using autologous tissue or prosthetic material to form a natural-looking breast. It is increasingly offered to women undergoing mastectomy for breast cancer. However, there is no systematic analysis available for the expanding area of research on breast reconstruction. METHODS: A bibliometric method was used to obtain a view of the scientific production about breast reconstruction by data extracted from the Institute for Scientific Information (ISI). Specific parameters were retrieved from the ISI. Articles about breast reconstruction were analyzed to obtain a view of the topic's structure, history, and document relationships using HistCite software. Trends in the most influential publications and authors were analyzed. RESULTS: The number of articles was constantly increasing. Most highly cited articles described the methods of flap construction in the surgery. Other highly cited articles discussed the psychological or emotional aspects of breast reconstruction, skin sparing mastectomy, and breast reconstruction in the irradiated breast. CONCLUSIONS: This was the first breast reconstruction scientometric analysis, representing the characteristics of papers and the trends of scientific production. A constant increase in the number of breast reconstruction papers and also the increasing number of citations shows that there is an increasing interest in this area of medical science. It seems that most of the research in this field is focused on the technical aspects of surgery.
Bibliometrics
;
Breast
;
Breast Neoplasms
;
Female
;
Historiography
;
Humans
;
Mammaplasty
;
Mastectomy
;
Research Design
;
Skin
2.Model Determination of Delayed Causes of Analgesics Prescription in the Emergency Ward in Arak, Iran.
Ali CYRUS ; Mehrdad MOGHIMI ; Abolfazle JOKAR ; Mohammad RAFEIE ; Ali MORADI ; Parisa GHASEMI ; Hanieh SHAHAMAT ; Ali KABIR
The Korean Journal of Pain 2014;27(2):152-161
BACKGROUND: According to the reports of the World Health Organization 20% of world population suffer from pain and 33% of them suffer to some extent that they cannot live independently. METHODS: This is a cross-sectional study which was conducted in the emergency department (ED) of Valiasr Hospital of Arak, Iran, in order to determine the causes of delay in prescription of analgesics and to construct a model for prediction of circumstances that aggravate oligoanalgesia. Data were collected during a period of 7 days. RESULTS: Totally, 952 patients participated in this study. In order to reduce their pain intensity, 392 patients (42%) were treated. Physicians and nurses recorded the intensity of pain for 66.3% and 41.37% of patients, respectively. The mean (SD) of pain intensity according to visual analogue scale (VAS) was 8.7 (1.5) which reached to 4.4 (2.3) thirty minutes after analgesics prescription. Median and mean (SD) of delay time in injection of analgesics after the physician's order were 60.0 and 45.6 (63.35) minutes, respectively. The linear regression model suggested that when the attending physician was male or intern and patient was from rural areas the delay was longer. CONCLUSIONS: We propose further studies about analgesics administration based on medical guidelines in the shortest possible time and also to train physicians and nurses about pain assessment methods and analgesic prescription.
Analgesics*
;
Attitude of Health Personnel
;
Cross-Sectional Studies
;
Emergencies*
;
Emergency Medicine
;
Emergency Service, Hospital*
;
Humans
;
Iran*
;
Linear Models
;
Male
;
Narcotics
;
Pain Measurement
;
Physician's Practice Patterns
;
Prescriptions*
;
World Health Organization
3.Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia.
Ali CYRUS ; Ali KABIR ; Davood GOODARZI ; Afsaneh TALAEI ; Ali MORADI ; Mohammad RAFIEE ; Mehrdad MOGHIMI ; Elham SHAHBAZI ; Elaheh FARMANI
Korean Journal of Urology 2014;55(12):814-820
PURPOSE: To investigate the effect of metabolic syndrome (MetS) on the response to medical therapy of benign prostatic hyperplasia (BPH) after a 3-month period of treatment. MATERIALS AND METHODS: This was a cohort study of 100 patients, 47 with MetS and 53 without MetS, referred to either the primary care unit or referral hospital with BPH who had moderate lower urinary tract symptoms of prostate involvement and were candidates for medical treatment. Our main outcome was response to medical treatment with prazosin 1 mg twice a day and finasteride 5 mg daily in patients with BPH on the basis of International Prostate Symptom Score (IPSS). Multivariate analysis of covariance was used to compare BPH treatment response in patients with and without MetS before and after receiving treatment. RESULTS: The mean volume of the prostate was significantly higher in MetS patients than in patients without MetS (57+/-32.65 mL compared with 46.00+/-20.19 mL, p=0.036). The control group demonstrated an 11-unit reduction in IPSS, whereas those with MetS showed a reduction in the symptom score of only 6 units (p<0.001). Regarding the components of MetS separately, triglyceride (p<0.001), fasting blood sugar (p=0.001), and waist circumference (p=0.028) significantly affected the clinical progression of BPH. The observational nature of this study may be a limitation in comparison with an interventional study. CONCLUSIONS: The results of the present study showed that MetS can negatively affect the response to medical treatment of BPH. Therefore, it is necessary to consider MetS in selecting patients with BPH for drug therapy.
Aged
;
Case-Control Studies
;
Finasteride/*therapeutic use
;
Humans
;
Lower Urinary Tract Symptoms/etiology
;
Male
;
Metabolic Syndrome X/*complications
;
Middle Aged
;
Patient Selection
;
Prazosin/*therapeutic use
;
Prostatic Hyperplasia/complications/*drug therapy/pathology
;
Treatment Outcome
;
Urological Agents/*therapeutic use